Euphorbia factor L1 is primarily studied for its potential in medical research, particularly in the field of oncology. It has shown promising anti-cancer properties, including the ability to inhibit the growth of certain cancer cells. Researchers are exploring its mechanism of action, which involves inducing apoptosis (programmed cell death) in malignant cells, making it a candidate for developing novel cancer therapies. Additionally, it is being investigated for its anti-inflammatory and analgesic effects, which could lead to its use in managing chronic pain or inflammatory conditions. Its natural origin from the Euphorbia plant also makes it a subject of interest in phytochemistry and drug discovery.